Chemokines mediate ethanol‐induced exacerbations of murine cockroach allergen asthma von Bouchard, J. C., Beal, D. R., Kim, J., Vaickus, L. J., Remick, D. G.

Volltext

Otelixizumab – dose regimen optimization of a chimeric/humanized aglycosylated anti-CD3 monoclonal antibody (MAb) in adult subjects with type 1 diabetes mellitus (T1DM) von Rosenzweig, M, Mehta, D, Forman, D, McKee, C, Vaickus, L

Volltext

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers von NG, Chee M, STEFANICH, Eric, ANAND, Banmeet S, FIELDER, Paul J, VAICKUS, Louis

Volltext

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity von MEROPOL, N. J, PORTER, M, CALIGIURI, M. A, BLUMENSON, L. E, LINDEMANN, M. J, PEREZ, R. P, VAICKUS, L, LOEWEN, G. M, CREAVEN, P. J, WILKES, K. A, GIEDLIN, M. A

Volltext

Immunoregulatory properties of TRX585, a novel monoclonal antibody specific for immunoglobulin-like transcript 5 von Apostolou, I., Guild, J., Vaickus, L., Rosenzweig, M.

Volltext

Levalbuterol hydrochloride von Handley, Dean A, Morley, John, Vaickus, Louis

Volltext

Development of TRX518, an aglycosyl humanized monoclonal antibody (Mab) agonist of huGITR von Rosenzweig, M., Ponte, J., Apostolou, I., Doty, D., Guild, J., Slavonic, M., Ponath, P., Vaickus, L.

Volltext

Effect of the antimouse GITR mab plus chemotherapy on survival and tumor immunity von Ponte, J., Doty, D., Christmas, R., Ponath, P., Vaickus, L., Rosenzweig, M.

Volltext

Otelixizumab Induces Expansion of Human CD4+FoxP3+ Cells in vitro von man, D, Vaickus, L, Rosenzweig, M

Volltext

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen von Foon, K A, Oseroff, A R, Vaickus, L, Greenberg, S J, Russell, D, Bernstein, Z, Pincus, S, Köhler, H, Seon, B K, Tahaoglu, E

Volltext

Malignancy‐related pericardial effusion. 127 cases from the roswell park cancer institute von Wilkes, John D., Fidias, Panos, Vaickus, Louis, Perez, Raymond P.

Volltext

Antiproliferative monoclonal antibodies: detection and initial characterization von Vaickus, L, Levy, R

Volltext

Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study von Nowak, Richard M, Emerman, Charles L, Schaefer, Kendyl, DiSantostefano, Rachel L, Vaickus, Louis, Roach, James M

Volltext

Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus von PAPSIDERO, L. D, DITTMER, R. P, VAICKUS, L, POIESZ, B. J

Volltext

Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T-Cell Lymphoma von CHATTERJEE, M., MROZEK, E., VAICKUS, L., OSEROFF, A., STOLL, H., RUSSELL, D., KOHLER, H., FOON, K. A.

Volltext

Expression of CD3 and T Cell Receptor (TCR) on a Minor Population of Human CD14 Positive Cells von Forman, Daron, Senior Scientist, Tolerx, Cambridge, MA, Rosenzweig, Michael, Senior Director of Preclinical Research, Tolerx, Cambridge, MA, Vaickus, Lou, Chief Medical Officer, Tolerx, Cambridge, MA

Volltext

Phase IA/IB Evaluation of Mammalian Cell-derived Glycosylated Recombinant Human Interleukin (SIGOSIX) before and after Cytotoxic Chemotherapy von RITCH, P. S., KEEVER, C., SCHILLER, J., RIVKIN, S., WITT, P. L., GROSSBERG, S. E., TRUITT, R. L., BURRIS, H., Von HOFF, D. D., VAICKUS, L., DRECHSLER, D., BORDEN, E. C., GALAZKA, A., BREITMEYER, J. B., ABDUL-AHAD, A.

Volltext

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease von BERNSTEIN, Z. P, VAICKUS, L, ZEFFREN, J, DENNIN, R. A, LEVITT, D, FOON, K. A, FRIEDMAN, N, GOLDROSEN, M. H, WATANABE, H, RAHMAN, R, ARBUCK, S. G, SWEENEY, J, VESPER, D, HENDERSON, E. D

Volltext

Consecutive doses of levalbuterol and racemic albuterol result in comparable safety and efficacy: A pharmacokinetic and pharmacodynamic study in mild-moderate asthmatics von Gumbhir-Shah, K, Koch, P, Jusko, W, Vaickus, L

Volltext

606 Norastemizole (NORA) acts earlier and is more effective for allergic rhinitis symptoms than loratadine (LAT) and placebo (PBO) in an allergen challenge system von Day, J.H, Briscoe, M.P, Rafeiro, E, DeGraw, S.S, Clancy, J, Taylor, A, Jarleski, D, Reasner, D, Vaickus, L

Volltext